Xiaolin Su
University of Science and Technology of China
ORCID: 0009-0003-9045-7257Also affiliated with University of Shanghai for Science and Technology, Guangxi University, Jinan University, Xiamen University, Dalian University of Technology, Southern University of Science and Technology, BeiGene (China), Zhejiang DongFang Vocational and Technical College, ShenZhen People’s Hospital, Institute of Metal Research, General Hospital of Shenyang Military Region, Southern Medical University Shenzhen Hospital, Shenzhen Luohu People's Hospital, Shenzhen Second People's Hospital, China Medical University, University of Science and Technology Beijing
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer”.
S. Louise Pay, Naveen Singh, I‐Ju Yeh, Snehal B. Bhandare, Xiaolin Su +5 more
Edward A. Motea, Xiumei Huang, Colton L. Starcher, Jayne M. Silver, I‐Ju Yeh +6 more
Xiaolin Su, Wentong Zhang, Yi-Hong Zhang, Xinghua Feng, Yonghua Ji +2 more
Lingxiang Jiang, Ting Fang, Fei Fang, Yingchun Liu, Ye Zhao +9 more
Jiangwei Wang, Lingxiang Jiang, Yaomin Chen, Tao Lu, Marc S. Mendonca +2 more
Yingchun Liu, Xiaolin Su, Jiangwei Wang, Ye Zhao, Soumya Tumbath +9 more
Yingchun Liu, Soumya Tumbath, Matthew W. Boudreau, Lindsay E. Chatkewitz, Jiangwei Wang +8 more